University of Florida: Diabetes Mellitus, Type 2 trials

The registry lists 16 Diabetes Mellitus, Type 2 studies with University of Florida as lead sponsor. 1 are open to participants now and 8 have results posted.

Phase 1 1Phase 2 2Phase 4 7No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Low-Dose Pioglitazone in Patients With NASH (AIM 2)RecruitingNCT04501406Phase 2
• Ticagrelor With and Without Aspirin in Patients With Diabetes MellitusCompletedNCT04484259Phase 4Results posted
• Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes MellitusCompletedNCT03774394Phase 4Results posted
• Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver DiseaseCompletedNCT03459079Phase 2Results posted
• Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCICompletedNCT03437044Phase 4Results posted
• Aspirin Dosing in Diabetic PatientsCompletedNCT01201785Phase 4Results posted
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
• Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 DiabetesCompletedNCT00998335Phase 4Results posted
• University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
• Medication Use Among American Indians AdultsWithdrawnNCT06053359
• Pilot RCT Feasibility Study: Cancer and T2DTerminatedNCT04468243Not applicable
• RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver DiseaseTerminatedNCT03365531Not applicable
• Effect of Aerobic Interval Training on Cardiovascular Function in Type 2 DiabetesCompletedNCT01883258Not applicable
• Periodontal Treatment Response in Type II Diabetic PatientsCompletedNCT01881074
• Effects of Treating Vitamin D Deficiency in Poorly Controlled Type 2 DiabetesCompletedNCT01855321Phase 1
• Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)CompletedNCT00130481Not applicable